Ai2's AutoDiscovery uncovers missed immune signal in breast cancer data

allen_ai · x · 2026-08-27

Ai2 announced a partnership with Providence Swedish Cancer Institute to deploy its AI-powered scientific discovery platform, AutoDiscovery, in cancer research. Early research showed AutoDiscovery identifying a stronger immune signature in invasive lobular breast cancer than previously recognized in a heavily studied dataset. This finding was validated across an independent patient cohort and lab analysis, marking a step from public datasets into active clinical research programs.

Related event: Ai2 and Providence Swedish partner to deploy AutoDiscovery, uncovering missed immune signals in breast cancer data(5 posts)→

Original post →

More from Apps

• Running Boltz-2 100M times to simulate cell biology — dom_beaini · 2026-08-27
• Voice Weather Agent Fails: The Importance of Evaluations — samuelcolvin · 2026-08-27
• GPT Image 2 prompt recipe: motion-trail hand-drawn annotations on photos — songguoxiansen · 2026-08-27
• Agno 3.0 Released: SDK to Build and Self-Manage Enterprise Agent Platforms — pritisinghhhh · 2026-08-27
• Longevity Deck hits 5,000 users, auto-building health timelines from wearables — michalmalewicz · 2026-08-27
• Salesforce's AI Identity Crisis: Defending the Present or Building the Future? — thedealdirector · 2026-08-27

Apps channel →